PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Satudora Holdings Co.,Ltd.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Satudora Holdings Co.,Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ¥2 per ¥100 of sales comes from others' credit, against ¥1 tied up three years earlier. Less money tied up than 90% of Healthcare companies in Japan.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 80% of its market value (net debt). Lower than 87% of Healthcare companies in Japan.

Where ¥100 of sales goes

¥99Operating costs¥0.2Interest¥0.4Net profit¥0.1Paid as dividends

Latest year (May 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

1.4×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.4 times.

Lower than 52% of Healthcare companies in Japan.

Cash Locked Ratio

−¥2

Money owed to suppliers is larger than money owed by customers plus stock: ¥2 per ¥100 of sales comes from others' credit, against ¥1 tied up three years earlier.

Less money tied up than 90% of Healthcare companies in Japan.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 71% of Healthcare companies in Japan.

Growth Efficiency Ratio

¥3

Sales grew 15% in 3 years; of every extra ¥100 of sales, ¥3 became extra profit.

Lower than 58% of Healthcare companies in Japan.

Asset Productivity Ratio

+15% / +5%

In 3 years sales changed by +15% while total assets changed by +5%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

1.4×

Debt due within a year is covered 1.4 times by its yearly operating cash.

Higher than 59% of Healthcare companies in Japan.

Cash Cushion Ratio

−80%

Debt, after subtracting cash, equals 80% of its market value (net debt).

Lower than 87% of Healthcare companies in Japan.

Tangible Assets Ratio

97%

Of every ¥100 the company owns, ¥97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 54% of Healthcare companies in Japan.

Tangible Net Worth Ratio

86%

Of every ¥100 of net worth, ¥86 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 64% of Healthcare companies in Japan.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 25% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Satudora Holdings Co.,Ltd. owes ¥0.77 for every ¥1 it owns. Net profit fell 43% in the year to May 2026, and grew 71% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results May 2026.

P/E ratio

104.2

Investors pay ¥104.2 for every ¥1 of Satudora Holdings Co.,Ltd.'s yearly profit, higher than 96% of Healthcare companies in Japan.

P/B ratio

1.70

The share price is 1.70 times Satudora Holdings Co.,Ltd.'s book value per share, higher than 56% of Healthcare companies in Japan.

Market cap

¥17.2 B

The total market value of all of Satudora Holdings Co.,Ltd.'s shares at today's price (share price × number of shares), larger than 50% of Healthcare companies in Japan. PosiCap size class: Mini Cap.

Net worth (book value)

¥10.1 B

What Satudora Holdings Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).

Book value per share

¥733.29

Net worth divided by the number of shares. The share price of ¥1,247 is 1.7 times this, which is the P/B above.

Return on equity (ROE)

1.5%

Satudora Holdings Co.,Ltd. earned 1.5% on its shareholders' money over the last year, lower than 72% of Healthcare companies in Japan.

Owes vs Owns

0.77×

Satudora Holdings Co.,Ltd. owes ¥0.77 for every ¥1 it owns (moderate), higher than 90% of Healthcare companies in Japan.

Dividend yield

None

Satudora Holdings Co.,Ltd. does not currently pay a dividend.

Revenue growth

+0%

Revenue rose 0% in the year to May 2026, and grew 5% a year on average over 3 years.

Profit growth

-43%

Net profit fell 43% in the year to May 2026, and grew 71% a year on average over 3 years.

Profit margin

0.4%

Satudora Holdings Co.,Ltd. keeps ¥0 of every ¥100 of revenue as net profit.

Cash quality

5.3×

Cash from Satudora Holdings Co.,Ltd.'s business was 5.3× its reported profit in the year to May 2026 — its profit turned into cash.

Interest cover

6.1×

Satudora Holdings Co.,Ltd.'s operating profit covered its interest costs 6.1 times in the year to May 2026.

Cash vs debt

Net debt

Satudora Holdings Co.,Ltd. had ¥13.7 B more debt than cash (net debt) at May 2026.

Questions

What is Satudora Holdings Co.,Ltd.'s P/E ratio?

Investors pay ¥104.2 for every ¥1 of Satudora Holdings Co.,Ltd.'s yearly profit, higher than 96% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Satudora Holdings Co.,Ltd.: ¥17.2 B ÷ ¥10.1 B (31 May 2026) = 1.7.

What is Satudora Holdings Co.,Ltd.'s return on equity?

Satudora Holdings Co.,Ltd. earned 1.5% on its shareholders' money over the last year, lower than 72% of Healthcare companies in Japan.

How much does Satudora Holdings Co.,Ltd. owe compared with what it owns?

Satudora Holdings Co.,Ltd. owes ¥0.77 for every ¥1 it owns (moderate), higher than 90% of Healthcare companies in Japan.

Does Satudora Holdings Co.,Ltd. pay a dividend?

No. Satudora Holdings Co.,Ltd. does not currently pay a dividend.

Is Satudora Holdings Co.,Ltd.'s revenue growing?

Revenue rose 0% in the year to May 2026, and grew 5% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.